Individual investors may submit written questions to IR at vaxart.com ... And at that point, there would be an interim analysis to look at the differences between the two vaccines. And again it's ...

Alstom's first half 2024/25: good commercial performance, confirmation of FY 2024/25 outlook H1 2024/25 highlights: Book-to-bill ratio at 1.25 and organic sales up 5.6%1aEBIT2 of €515 million, up 18% ...

MeidasTouch host Brett Meiselas reports on Trump voters losing it after they either realize that Trump is a complete and ...